Multiple Sclerosis UK Posts - TopicsExpress

Using no-evidence-of-disease-activity standard for patients with
Using no-evidence-of-disease-activity standard for patients with multiple sclerosis Maintaining no-evidence-of-disease-activity (NEDA) was difficult ...

Thrice-weekly Copaxone dosing receives pelminary positive outcome
Thrice-weekly Copaxone dosing receives pelminary positive outcome in Europe Teva Pharmaceutical Industries Ltd. announced that its thrice-weekly Copa...

Researchers identify chemical compound that decreases effects of
Researchers identify chemical compound that decreases effects of multiple sclerosis Given such debilitating effects of MS, an aggressive search is on...

Inability to recognize and convey emotion a symptom of MS What
Inability to recognize and convey emotion a symptom of MS What may be overlooked in relating to and caring for patients with multiple sclerosis is th...

New trial in primary progressive multiple sclerosis for Laquinimod
New trial in primary progressive multiple sclerosis for Laquinimod Teva Pharmaceutical Industries Ltd. and Active Biotech today announced the expans...

Ride like the wind for MS-UK RideLondon, the UK’s biggest
Ride like the wind for MS-UK RideLondon, the UK’s biggest sportive, is a fantastic event that will see you complete 100 miles starting at the Olymp...

Want an adventure in 2015? Now the summer holidays are over, it
Want an adventure in 2015? Now the summer holidays are over, it is time to turn your mind to 2015. To celebrate Pachamama, an annual celebration in ...

Successful phase 2a clinical study reinforces novel approach to
Successful phase 2a clinical study reinforces novel approach to treat Multiple Sclerosis GeNeuro SA announced today positive results from a one-year,...